Rene Nunez Selected Research

Fatigue

12/2016	Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial.
6/2015	A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rene Nunez Research Topics

Disease

8	Major Depressive Disorder (Major Depressive Disorders) 12/2016 - 01/2014
5	Nausea 12/2016 - 01/2014
4	Diarrhea 12/2016 - 11/2014
3	Anxiety Disorders (Anxiety Disorder) 12/2016 - 06/2015
3	Dizziness (Lightheadedness) 12/2016 - 01/2014
2	Erectile Dysfunction 12/2016 - 01/2014
2	Fatigue 12/2016 - 06/2015
2	Vomiting 06/2015 - 03/2015
1	Movement Disorders (Movement Disorder) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Ejaculatory Dysfunction 12/2016
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2015
1	Constipation 01/2014
1	Hyperhidrosis 01/2014

Drug/Important Bio-Agent (IBA)

7	Vilazodone HydrochlorideIBA 12/2016 - 11/2014
4	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2016 - 03/2015
3	5-HT1A Serotonin ReceptorIBA 12/2016 - 06/2015
1	pimavanserinIBA 01/2020
1	Citalopram FDA LinkGeneric 07/2015
1	Serotonin (5 Hydroxytryptamine)IBA 11/2014
1	LevomilnacipranIBA 01/2014